Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
16 Apr 2020 03:17 PM
RNS
Notice of Results Update
08 Apr 2020 07:00 AM
RNS
Oxford Biomedica joins COVID-19 vaccine Consortium
01 Apr 2020 09:31 AM
RNS
Total Voting Rights
25 Mar 2020 01:06 PM
RNS
Director Dealings / Market Share Purchase
20 Mar 2020 09:56 AM
RNS
Director/PDMR Shareholding
18 Mar 2020 07:00 AM
RNS
Oxford Biomedica Business Update
18 Mar 2020 07:00 AM
RNS
License & Supply Agreement with Juno Therapeutics
02 Mar 2020 09:22 AM
RNS
Total Voting Rights
26 Feb 2020 05:55 PM
RNS
Director Dealings / Market Share Purchase
03 Feb 2020 05:04 PM
RNS
Class 2 Transaction Announcement
03 Feb 2020 11:56 AM
RNS
Total Voting Rights
03 Feb 2020 11:55 AM
RNS
Director Dealings / Market Share Purchase
22 Jan 2020 12:11 PM
RNS
Block listing Application
07 Jan 2020 10:17 AM
RNS
Block Listing Return
02 Jan 2020 11:41 AM
RNS
Total Voting Rights
19 Dec 2019 03:27 PM
RNS
Director Dealings / Market Share Purchase
19 Dec 2019 07:00 AM
RNS
Extension of Commercial Supply Agreement
02 Dec 2019 09:31 AM
RNS
Total Voting Rights
27 Nov 2019 10:05 AM
RNS
Director Dealings / Market Share Purchase
13 Nov 2019 04:41 PM
RNS
Holding(s) in Company
01 Nov 2019 09:25 AM
RNS
Total Voting Rights
28 Oct 2019 12:30 PM
RNS
Director Dealings / Market Share Purchase
23 Oct 2019 07:00 AM
RNS
Holding(s) in Company
23 Oct 2019 07:00 AM
RNS
Holding(s) in Company
16 Oct 2019 07:30 AM
EQS
Oxford BioMedica (OXB): Demanding second half
01 Oct 2019 10:18 AM
RNS
Total Voting Rights
25 Sep 2019 11:41 AM
RNS
Director Dealings / Market Share Purchase
16 Sep 2019 11:18 AM
RNS
Director/PDMR Shareholding
16 Sep 2019 09:15 AM
RNS
Directors Dealings / Market Share Purchases
13 Sep 2019 02:57 PM
RNS
Long Term Incentive Plan Option Grant
13 Sep 2019 01:13 PM
RNS
Directors Dealings / Market Share Purchases
13 Sep 2019 10:53 AM
RNS
Director Dealings / Market Share Purchase
04 Sep 2019 07:00 AM
RNS
Oxford Biomedica Interim Results
02 Sep 2019 09:31 AM
RNS
Total Voting Rights
23 Aug 2019 11:06 AM
RNS
Director Dealings / Market Share Purchase
09 Aug 2019 12:00 PM
RNS
Notice of Interim Results
01 Aug 2019 09:18 AM
RNS
Total Voting Rights
25 Jul 2019 02:17 PM
RNS
Director Dealings / Market Share Purchase
01 Jul 2019 11:03 AM
EQS
Oxford BioMedica (OXB): Eying up long-term value
01 Jul 2019 10:01 AM
RNS
Block listing Interim Review
01 Jul 2019 09:32 AM
RNS
Total Voting Rights
28 Jun 2019 07:00 AM
RNS
Repayment of Debt Facility
26 Jun 2019 02:52 PM
RNS
Director Dealings / Market Share Purchase
26 Jun 2019 07:00 AM
RNS
OXB and Santen enter R&D collaboration
25 Jun 2019 07:00 AM
RNS
Board Change
18 Jun 2019 07:15 AM
EQS
Oxford BioMedica (OXB): De-leveraging the balan...
10 Jun 2019 02:34 PM
RNS
Director/PDMR Shareholding
06 Jun 2019 01:08 PM
RNS
Axovant update on 1st cohort of Sunrise-PD trial
06 Jun 2019 11:39 AM
RNS
Holding(s) in Company
05 Jun 2019 12:06 PM
RNS
Holdings in Company

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100